Jilin Province Huinan Changlong Bio-pharmacy Co Ltd banner
J

Jilin Province Huinan Changlong Bio-pharmacy Co Ltd
HKEX:8049

Watchlist Manager
Jilin Province Huinan Changlong Bio-pharmacy Co Ltd
HKEX:8049
Watchlist
Price: 2.27 HKD -1.3%
Market Cap: HK$1.3B

Profitability Summary

Jilin Province Huinan Changlong Bio-pharmacy Co Ltd's profitability score is 53/100. We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

53 / 100
Profitability
Score

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

53 / 100
Profitability
Score
53 / 100
Profitability
Score

Margins

Earnings Waterfall
Jilin Province Huinan Changlong Bio-pharmacy Co Ltd

Margins Comparison
Jilin Province Huinan Changlong Bio-pharmacy Co Ltd Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
CN
Jilin Province Huinan Changlong Bio-pharmacy Co Ltd
HKEX:8049
1.3B HKD
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
869B USD
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
588.6B USD
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
248.4B CHF
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
227.8B GBP
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
297.7B USD
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
229.9B CHF
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
237.1B USD
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
159.7B USD
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1T DKK
Loading...
Loading...
Loading...
US
Bristol-Myers Squibb Co
NYSE:BMY
122.1B USD
Loading...
Loading...
Loading...

Return on Capital

Return on Capital Comparison
Jilin Province Huinan Changlong Bio-pharmacy Co Ltd Competitors

Country Company Market Cap ROE ROA ROCE ROIC
CN
Jilin Province Huinan Changlong Bio-pharmacy Co Ltd
HKEX:8049
1.3B HKD
Loading...
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
869B USD
Loading...
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
588.6B USD
Loading...
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
248.4B CHF
Loading...
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
227.8B GBP
Loading...
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
297.7B USD
Loading...
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
229.9B CHF
Loading...
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
237.1B USD
Loading...
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
159.7B USD
Loading...
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1T DKK
Loading...
Loading...
Loading...
Loading...
US
Bristol-Myers Squibb Co
NYSE:BMY
122.1B USD
Loading...
Loading...
Loading...
Loading...

Free Cash Flow

Free Cash Flow Analysis
Jilin Province Huinan Changlong Bio-pharmacy Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett